165 related articles for article (PubMed ID: 7695232)
21. Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.
Martínez-Mir MI; Pollard H; Moreau J; Traiffort E; Ruat M; Schwartz JC; Palacios JM
Synapse; 1993 Nov; 15(3):209-20. PubMed ID: 7904088
[TBL] [Abstract][Full Text] [Related]
22. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
Cenci MA; Lee CS; Björklund A
Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
[TBL] [Abstract][Full Text] [Related]
23. Striatal preprotachykinin and preproenkephalin mRNA levels and the levels of nigral substance P and pallidal Met5-enkephalin depend on corticostriatal axons that use the excitatory amino acid neurotransmitters aspartate and glutamate: quantitative radioimmunocytochemical and in situ hybridization evidence.
Somers DL; Beckstead RM
Brain Res Mol Brain Res; 1990 Jul; 8(2):143-58. PubMed ID: 1698246
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide induces preproenkephalin transcription in hypophysiotropic neurons of the rat paraventricular hypothalamic nucleus suggesting a neuroendocrine role for enkephalins during immune stress.
Engström L; Mackerlova L; Blomqvist A
Neuroscience; 2006 Oct; 142(3):781-8. PubMed ID: 16949213
[TBL] [Abstract][Full Text] [Related]
25. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.
Menalled L; Zanjani H; MacKenzie L; Koppel A; Carpenter E; Zeitlin S; Chesselet MF
Exp Neurol; 2000 Apr; 162(2):328-42. PubMed ID: 10739639
[TBL] [Abstract][Full Text] [Related]
26. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
27. Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.
Desplats PA; Kass KE; Gilmartin T; Stanwood GD; Woodward EL; Head SR; Sutcliffe JG; Thomas EA
J Neurochem; 2006 Feb; 96(3):743-57. PubMed ID: 16405510
[TBL] [Abstract][Full Text] [Related]
28. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study.
Augood SJ; Faull RL; Love DR; Emson PC
Neuroscience; 1996 Jun; 72(4):1023-36. PubMed ID: 8735227
[TBL] [Abstract][Full Text] [Related]
29. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
Nisbet AP; Foster OJ; Kingsbury A; Eve DJ; Daniel SE; Marsden CD; Lees AJ
Neuroscience; 1995 May; 66(2):361-76. PubMed ID: 7477878
[TBL] [Abstract][Full Text] [Related]
30. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
[TBL] [Abstract][Full Text] [Related]
31. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.
Norris PJ; Waldvogel HJ; Faull RL; Love DR; Emson PC
Neuroscience; 1996 Jun; 72(4):1037-47. PubMed ID: 8735228
[TBL] [Abstract][Full Text] [Related]
32. Quantitative non-radioactive in situ hybridization of preproenkephalin mRNA with digoxigenin-labeled cRNA probes.
Robbins E; Baldino F; Roberts-Lewis JM; Meyer SL; Grega D; Lewis ME
Anat Rec; 1991 Dec; 231(4):559-62. PubMed ID: 1793181
[TBL] [Abstract][Full Text] [Related]
33. Huntington's disease: survival of large striatal neurons in the rigid variant.
Bugiani O; Tabaton M; Cammarata S
Ann Neurol; 1984 Feb; 15(2):154-6. PubMed ID: 6230987
[TBL] [Abstract][Full Text] [Related]
34. A morphometric reevaluation of Huntington's chorea with special reference to the large neurons in the neostriatum.
Oyanagi K; Ikuta F
Clin Neuropathol; 1987; 6(2):71-9. PubMed ID: 2954733
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents.
Uhl GR; Navia B; Douglas J
J Neurosci; 1988 Dec; 8(12):4755-64. PubMed ID: 2904494
[TBL] [Abstract][Full Text] [Related]
36. A quantitative investigation of the substantia nigra in Huntington's disease.
Oyanagi K; Takeda S; Takahashi H; Ohama E; Ikuta F
Ann Neurol; 1989 Jul; 26(1):13-9. PubMed ID: 2528318
[TBL] [Abstract][Full Text] [Related]
37. N-methyl-D-aspartate receptor antagonism alters substance P and met5-enkephalin biosynthesis in neurons of the rat striatum.
Somers DL; Beckstead RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):823-33. PubMed ID: 1380083
[TBL] [Abstract][Full Text] [Related]
38. Enkephalinergic striatal projection neurons become less affected by quinolinic acid than substance P-containing striatal projection neurons as rats age.
Sun Z; Chen Q; Reiner A
Exp Neurol; 2003 Dec; 184(2):1034-42. PubMed ID: 14769398
[TBL] [Abstract][Full Text] [Related]
39. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons.
Pollack AE; Wooten GF
Brain Res Mol Brain Res; 1992 Mar; 13(1-2):35-41. PubMed ID: 1315917
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice.
Denovan-Wright EM; Robertson HA
Neuroscience; 2000; 98(4):705-13. PubMed ID: 10891614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
